早产与儿童及成人肾小球疾病不良结局的关联
本研究基于Cure Glomerulonephropathy队列,比较早产(<37周)与足月(≥37周)肾小球疾病患者。早产者肾病进展风险更高、蛋白尿完全缓解率更低,且成人早产者APOL1高危基因型及FSGS更常见。
要点
- 早产是肾小球疾病不良结局的危险因素。
- 调整FSGS和APOL1风险状态后,早产者缓解更少、进展更快。
- 成人早产者APOL1高危基因型及FSGS患病率更高。
核心结论
- 早产是儿童和成人肾小球疾病不良结局的危险因素。
- 调整诊断和APOL1风险状态后,早产者蛋白尿缓解更少、肾脏病进展更快。
- 成人早产者更常见APOL1高危基因型及FSGS。
研究设计与样本
- Cure Glomerulonephropathy队列的横断面和纵向分析。
- 比较早产(<37周妊娠)与足月(≥37周妊娠)参与者,共2205例足月和235例早产。
- 采用生存分析和校正Cox比例风险模型评估复合结局(eGFR下降40%或进展至肾衰竭),校正logistic回归模型评估蛋白尿缓解。
主要发现
- 早产参与者从肾活检至eGFR下降40%/肾衰竭的时间间隔更短(P=0.001)。
- 儿童参与者早产比例高于成人:12.8% vs 7.69%(P<0.001)。
- 成人早产者相比足月者,FSGS患病率更高(35% vs 25%,P=0.01),APOL1高危基因型更常见(9.4% vs 4.2%,P=0.01)。
关键数值与推荐
- 早产定义为<37周妊娠,足月定义为≥37周妊娠。
- 复合结局为eGFR下降40%或进展至肾衰竭。
临床怎么用
- 对肾小球疾病患者应关注早产史,早产者可能需更密切监测蛋白尿缓解及肾功能进展。
- 成人早产肾小球疾病患者可考虑APOL1风险基因型检测及FSGS评估。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: Preterm birth was a risk factor for adverse outcomes in this heterogeneous cohort of children and adults with glomerular disease. In analyses adjusted for diagnosis and apolipoprotein L1 risk status, there was less remission and faster progression of kidney disease in those born preterm. A novel finding from this study is that adults born preterm were more likely to have an apolipoprotein L1 high-risk genotype. BACKGROUND: While some studies of children with nephrotic syndrome have demonstrated worse outcomes in those born preterm compared with term, little data exist on associations of preterm birth with outcomes in adult-onset glomerular disease. Cardiovascular outcomes in those born preterm with glomerular disease are unknown. METHODS: We performed a cross-sectional and longitudinal analysis of participants in the Cure Glomerulonephropathy cohort. Preterm (<37 weeks' gestation) was compared with term (≥37 weeks' gestation). A survival analysis and adjusted Cox proportional hazards model were used to examine a composite outcome of 40% decline in eGFR or progression to kidney failure. An adjusted logistic regression model was used to examine remission of proteinuria. RESULTS: There were 2205 term and 235 preterm participants. Apolipoprotein L1 (APOL1) risk alleles were more common in those born preterm. More pediatric than adult participants in Cure Glomerulonephropathy were born preterm: 12.8% versus 7.69% (P < 0.001). Adults born preterm compared with term had a higher prevalence of FSGS (35% versus 25%, P = 0.01) and APOL1 high-risk genotype (9.4% versus 4.2%, P = 0.01). Participants born preterm had a shorter time interval to a 40% eGFR decline/kidney failure after biopsy (P = 0.001). In adjusted analysis, preterm participants were 28% more likely to develop 40% eGFR decline/kidney failure (hazard ratio: 1.28 [1.07 to 1.54], P = 0.008) and 38% less likely to attain complete remission of proteinuria (odds ratio: 0.62 [0.45 to 0.87], P = 0.006). There was no significant difference in cardiovascular events. CONCLUSIONS: Preterm birth was a risk factor for adverse outcomes in this heterogeneous cohort of children and adults with glomerular disease. Adults born preterm were more likely to have an APOL1 high-risk genotype and FSGS. In analyses adjusted for FSGS and APOL1 risk status, there was less remission and faster progression of kidney disease in those born preterm.
引用
- Isaac JS, Troost JP, Wang Y, et al. Association of Preterm Birth with Adverse Glomerular Disease Outcomes in Children and Adults. Clin J Am Soc Nephrol. 2024. PMID: 38728081. doi:10.2215/CJN.0000000000000475
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。